Novo Nordisk (0QIU – Research Report) received a Hold rating and a DKK600.00 price target from Bernstein analyst Florent Cespedes today. The ...
Hosted on MSN20d
Novo Nordisk invests $1.2bn in new Denmark facilityDenmark-based pharma giant Novo Nordisk has announced plans to invest DKr8.5bn ($1.2bn) to establish a new production facility in Odense, Denmark. Announcing the news yesterday (16 December) ...
Orbis emerged from stealth in February 2024 with $28.1 million in seed funding. The Danish biotech, which aims to flip ...
Novo Nordisk retains a strong market position in a high-growth industry, with P/E multiples poised to expand. See why NVO ...
Much of the recent debate on closing Europe’s innovation gap with the US and China has centred on top-down policy initiatives ...
Two new studies suggest that the diabetes medication Ozempic may double the risk of a rare but serious condition that damages ...
It hasn’t been a smooth year for the two pharma giants, but events in the fourth quarter widened the gap between them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback